About this tutorial:
Video duration: 03:57:57
On March 8, 2021, FDA hosted a public meeting on Patient-Focused Drug Development for Vitiligo. FDA was interested in obtaining patient perspectives on the health effects and daily impacts of vitiligo, treatment goals, and decision factors considered when seeking out or selecting a treatment. For more information, visit the meeting webpage.